New North Card Completing Gas Source Transformation of RTO System
Release time:
2020-08-14
New North Card Completed Gas Source Transformation of RTO System
News from our newspaper Recently, Anhui New North Card Chemical Co., Ltd. reformed the gas source of RTO system, applying idle air compressors to RTO system and VOCs online system.
Anhui Xinbei Card generally consumes 8-10 tons / according to the original operation. After RTO was put into operation, the consumption of liquid nitrogen increased significantly. For this reason, the equipment department organized and carried out nitrogen leak detection work. it was found that the design liquid nitrogen consumption of RTO system was 24 tons / months, and the actual consumption was basically maintained at 15 tons / months.
Anhui Xinbei Card has a 7.5 kW screw air compressor with a displacement of 1.2 cubic meters / hours idle, which is calculated to meet the air consumption of RTO system and VOCs online system. As a result, Anhui Xinbei Card moved the original 5.5 kW VOCs special air compressor to the sewage station, changed the idle air compressor to compressed air, and applied it to the RTO system and the VOCs online system. After a day of intense construction, the renovation was completed and RTO was in normal operation.
RTO is the waste gas incinerator that uses the heat generated by the combustion of auxiliary fuel to increase the temperature of combustible harmful gases to the reaction temperature, thereby causing oxidation and decomposition. The more commonly used fuels are diesel, heavy oil and natural gas, but the processing cost is higher. The new North Card adopts electric heating RTO , the treatment efficiency reaches above 95% , and the methanol absorption liquid generated by the waste gas treatment in the workshop can be used as fuel, thus saving electricity consumption and relatively low treatment cost. In addition, the use of electric heating RTO , no longer produce new pollution factors, such as SO2 , NOx , etc. According to the calculation of the operating cost in the past two months, all electric heating is used. when the operating power consumption of RTO is about 1200 kW, and when the alternating methanol is about 500 kW, the online index of VOCs is below 10 mg / cubic meters (national standard 120 mg / cubic meters) on average. According to the calculation of liquid nitrogen consumption, it is estimated that 2 yuan can be saved every month. (Lu Xianhui)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page